Kraig Biocraft Labs Stock Current Asset
| KBLB Stock | USD 0.09 0.00 0.00% |
Kraig Biocraft Labs fundamentals help investors to digest information that contributes to Kraig Biocraft's financial success or failures. It also enables traders to predict the movement of Kraig OTC Stock. The fundamental analysis module provides a way to measure Kraig Biocraft's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kraig Biocraft otc stock.
Kraig |
Kraig Biocraft Labs OTC Stock Current Asset Analysis
Kraig Biocraft's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Kraig Biocraft Current Asset | 356 K |
Most of Kraig Biocraft's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kraig Biocraft Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Kraig Biocraft Labs has a Current Asset of 356 K. This is 99.99% lower than that of the Chemicals sector and 99.97% lower than that of the Materials industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Kraig Fundamentals
| Return On Asset | -0.32 | |||
| Current Valuation | 34.14 M | |||
| Shares Outstanding | 1.02 B | |||
| Shares Owned By Insiders | 25.29 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | (9.37) X | |||
| Price To Sales | 1,199 X | |||
| EBITDA | (2.64 M) | |||
| Net Income | (8.05 M) | |||
| Cash And Equivalents | 4.82 M | |||
| Total Debt | 95.24 K | |||
| Current Ratio | 0.53 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 38 | |||
| Beta | 0.34 | |||
| Market Capitalization | 38.03 M | |||
| Total Asset | 3.02 M | |||
| Retained Earnings | (22.47 M) | |||
| Working Capital | (2.32 M) | |||
| Current Asset | 356 K | |||
| Current Liabilities | 2.68 M | |||
| Net Asset | 3.02 M |
About Kraig Biocraft Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kraig Biocraft Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kraig Biocraft using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kraig Biocraft Labs based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kraig OTC Stock
Kraig Biocraft financial ratios help investors to determine whether Kraig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kraig with respect to the benefits of owning Kraig Biocraft security.